Fixed-Dose Subcutaneous C1-Inhibitor Liquid for Prophylactic Treatment of C1-INH-HAE: SAHARA Randomized Study

ConclusionFixed-dose subcutaneous pdC1-INH liquid was superior to placebo in preventing HAE attacks and demonstrated a favorable safety profile.

Source: The Journal of Allergy and Clinical Immunology: In Practice - January 23, 2019 Category: Allergy & Immunology Source Type: research